New HHS Rule Provides Public with More Information about Clinical Trials

PUBLISHED: Oct 12, 2016
Source: Department of Health and Human Services

The U.S. Department of Health and Human Services (HHS) recently issued a final rule that specifies requirements for registering certain clinical trials and submitting summary results information to ClinicalTrials.gov. The new rule expands the legal requirements for submitting registration and results information for clinical trials involving U.S. Food and Drug Administration-regulated drug, biological and device products. The National Institutes of Health has issued a complementary policy for registering and submitting summary results information to ClinicalTrials.gov for all NIH-funded trials, including those not subject to the final rule.

According to HHS, expanding the registration information in ClinicalTrials.gov improves people’s ability to find clinical trials in which they may be able to participate and access investigational therapies. More information about the scientific results of trials, whether positive or negative, may help inform healthcare providers and patients regarding medical decisions. Additional information will help researchers avoid unnecessary duplication of studies, focus on areas in need of study and improve study designs, ultimately advancing the development of clinical interventions.

Key elements of the final rule include:

  • Providing a checklist for evaluating which clinical trials are subject to the regulations and who is responsible for submitting required information;
  • Expanding the scope of trials for which summary results information must be submitted to include trials involving FDA-regulated products that have not yet been approved, licensed, or cleared by the FDA;
  • Requiring additional registration and summary results information data elements to be submitted to ClinicalTrials.gov, including the race and ethnicity of trial participants, if collected, and the full protocol;
  • Requiring additional types of adverse event information; and
  • Providing a list of potential legal consequences for non-compliance.

Follow the link below to access the final rule.

Want to read the full alert and receive alert emails?

Browse Additional Alerts